STOCK TITAN
  1. Home
  2. RUBY

Rubius Therapeutics (RUBY) Stock Price, News & Analysis

RUBY OTC

Company Description

Rubius Therapeutics (OTC: RUBY) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for RUBY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
90.5M
Shares outstanding

Latest News

View All
-9.24%

Rubius Therapeutics Announces Process to Explore Strategic Alternatives and Leadership Changes

management
-3.72%

Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference

conferences
-13.36%

Rubius Therapeutics Announces Strategic Update

-13.36%

Rubius Therapeutics to Provide Strategic Update

+0.90%

Rubius Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

earnings
-4.11%

Rubius Therapeutics to Announce Second Quarter 2022 Financial Results

earnings

Rubius Therapeutics has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include management, conferences, earnings. View all RUBY news →

SEC Filings

View All

No SEC filings available for RUBY.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

RUBY Company Profile & Sector Positioning

Rubius Therapeutics (RUBY) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.